Pro-inflammatory cytokines and inflammatory mediators

Pro-inflammatory cytokines and inflammatory mediators are a broad category of signaling molecules, such as TNF-α, IL-1β, and IL-6, that are essential for initiating and maintaining the immune response to injury or infection (StatPearls, 2023). Pathway-level modulation involves targeting the integrated signaling cascades—including the JAK/STAT and NF-κB pathways—that these molecules activate to promote the transcription of inflammatory genes (NIH, 2021). While these mediators are necessary for host defense, their dysregulation leads to chronic inflammation and tissue destruction in diseases like rheumatoid arthritis, Crohn's disease, and systemic lupus erythematosus (Nature Reviews Rheumatology, 2019). Pharmacological interventions range from biologics that sequester specific cytokines to small molecules that inhibit intracellular signal transducers. Because these pathways are central to immune surveillance, their inhibition can lead to significant safety concerns, most notably an increased risk of serious opportunistic infections and potential long-term risks of malignancy (PubMed, 2022).

Other names

Inflammatory cytokinesPro-inflammatory mediatorsInflammatory signaling pathwaysCytokine network

Therapeutic modulation is achieved through several distinct mechanisms: direct neutralization of soluble cytokines using monoclonal antibodies or decoy receptors, competitive blockade of cell-surface cytokine receptors, and the inhibition of downstream intracellular signaling components such as Janus kinases (JAKs) or the NF-κB complex (Nature Reviews Drug Discovery, 2018; StatPearls, 2023).